시장 개요
올리고뉴클레오티드는 일반적으로 자동화된 합성기를 사용하여 만들어진 단쇄 RNA 또는 DNA입니다. 올리고뉴클레오타이드 치료법은 특정 유전자의 발현을 억제할 수 있고 그 발달이 화학적으로 변형된 원시 핵산을 사용하여 일어난다는 점에서 기존 의학과 다릅니다. 이는 특정 유전자를 표적으로 하고 만성 질환을 치료하는 새로운 올리고뉴클레오티드의 개발로 이어집니다. 이는 전염병, 종양학, 신장 질환 및 심혈관 질환과 같은 응용 분야에 광범위하게 사용됩니다.시장 범위
"2028년까지의 글로벌 올리고뉴클레오티드 기반 치료법 시장 분석"은 글로벌 시장 동향 분석에 특별히 초점을 맞춘 의료 산업에 대한 전문적이고 심층적인 연구입니다. 이 보고서는 유형, 응용 분야 및 지역별로 상세한 시장 세분화를 통해 올리고뉴클레오티드 기반 치료법 시장에 대한 개요를 제공하는 것을 목표로 합니다. 이 보고서는 주요 올리고뉴클레오티드 기반 치료법 시장 플레이어의 시장 상태에 대한 주요 통계를 제공하고 시장의 주요 추세와 기회를 제공합니다.시장 세분화
- • 유형에 따라 전 세계 올리고뉴클레오티드 기반 치료법 시장은 안티센스, 리보자임, 앱타머, miRNA, CpG/면역자극 및 RNAi로 분류됩니다. • 응용 분야에 따라 시장은 전염병, 종양학, 신경퇴행성 장애, 심혈관 질환, 신장 질환 등으로 구분됩니다.
시장 역동성
동인
- • 암 및 전염병 발병률 증가와 신경퇴행성 질환에 대한 맞춤형 의약품의 필요성이 올리고뉴클레오티드를 촉진할 것으로 예상됩니다. 기반 치료법 시장. • 새로운 치료법에 대한 수요 증가와 혁신적인 새로운 올리고뉴클레오티드의 성장으로 시장 성장이 촉진됩니다. • 라이센싱 및 협력 활동 증가와 올리고뉴클레오티드 치료제의 고급 기술에 대한 수요 증가가 시장 성장을 촉진합니다.
제약
- • 미량 항체를 감지할 수 없음.
지역적 프레임워크
이 보고서는 질적 및 양적 정보를 모두 포함하여 업계에 대한 자세한 개요를 제공합니다. 다양한 부문을 기반으로 글로벌 시장에 대한 개요 및 예측을 제공합니다. 또한 5개 주요 지역에 대해 2019년부터 2028년까지 시장 규모와 예측 추정치를 제공합니다. 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미. 각 지역별 올리고뉴클레오티드 기반 치료법 시장은 나중에 각 국가 및 부문별로 세분화됩니다. 이 보고서는 전 세계 18개국에 대한 분석 및 예측과 함께 이 지역에 만연한 현재 추세 및 기회를 다루고 있습니다. 이 보고서는 수요와 공급 측면 모두에서 시장에 영향을 미치는 요인을 분석하고 예측 기간 동안 시장에 영향을 미치는 시장 역학, 즉 동인, 제한 사항, 기회 및 미래 추세를 추가로 평가합니다. 이 보고서는 또한 5개 지역 모두에 대한 철저한 PEST 분석을 제공합니다. 북미, 유럽, APAC, MEA 및 남미 지역의 올리고뉴클레오티드 기반 치료법 시장에 영향을 미치는 정치적, 경제적, 사회적 및 기술적 요인을 평가한 후.코로나19가 올리고뉴클레오티드 기반 치료제 시장에 미치는 영향
코로나19는 2019년 12월 중국 우한에서 처음 발생한 이후 빠른 속도로 전 세계로 확산되었습니다. 미국, 인도, 브라질, 러시아, 프랑스, 영국, 터키, 이탈리아 및 스페인은 확인 된 사례 및보고 된 사망 측면에서 가장 큰 피해를 입은 국가 중 일부입니다. 팬데믹이 발생하면서, 코로나19 팬데믹 기간 동안 부과된 전 세계적인 제한 및 폐쇄로 인해 올리고뉴클레오티드 기반 약물 판매가 소폭 감소했습니다. 그러나 제약회사와 바이오제약회사들은 올리고뉴클레오티드 시장의 플레이어들과 함께 올리고 제품을 제공함으로써 전세계적인 연구 노력에 기여하기로 나섰습니다. 이들 제품은 신종 코로나바이러스 감염을 표적으로 하는 테스트 키트, 치료제, 백신 개발에 사용됐다. 시장 참여자들의 다양한 계획과 코로나바이러스 연구에서 프로브 및 프라이머와 같은 광범위한 올리고뉴클레오티드 제품의 사용은 연구자들이 바이러스에 대해 더 나은 통찰력을 얻는 데 도움이 되었습니다. 따라서 올리고뉴클레오티드 시장은 향후 몇 년 동안 성장을 목격할 것으로 추정됩니다.시장 참여자
이 보고서는 유기 및 무기 성장 전략으로서 올리고뉴클레오티드 기반 치료법 시장의 주요 발전 사항을 다루고 있습니다. 다양한 기업들이 제품 출시, 제품 승인, 특허, 이벤트 등 유기적인 성장 전략에 주력하고 있습니다. 시장에서 목격된 무기 성장 전략 활동은 인수, 파트너십 및 협업이었습니다. 이러한 활동은 시장 참가자의 비즈니스 및 고객 기반 확장을 위한 기반을 마련했습니다. 올리고뉴클레오티드 기반 치료법 시장의 시장 참가자들은 글로벌 시장에서 올리고뉴클레오티드 기반 치료법에 대한 수요가 증가함에 따라 미래에 수익성 있는 성장 기회를 가질 것으로 예상됩니다. 이 보고서에는 올리고뉴클레오티드 기반 치료법 시장의 SWOT 분석 및 시장 전략과 함께 주요 회사의 프로필도 포함되어 있습니다. 또한 이 보고서는 회사 프로필, 구성 요소 및 제공되는 서비스, 지난 3년간의 재무 정보, 지난 5년간의 주요 개발과 같은 정보를 제공하는 업계 선두 기업에 중점을 둡니다.- • PCI 생명공학 • SomaGenics • InteRNA 기술 • Frontiers • miragen Therapeutics, Inc. • Ionis Pharmaceuticals, Inc. • Aligos Therapeutics • Gilead Sciences, Inc. • Biogen Inc. • Regulus Therapeutics Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. PCI Biotech
2. SomaGenics
3. InteRNA Technologies
4. Frontiers
5. miRagen Therapeutics, Inc.
6. Ionis Pharmaceuticals, Inc.
7. Aligos Therapeutics
8. Gilead Sciences, Inc.
9. Biogen Inc.
10. Regulus Therapeutics Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)